Mutual of America Capital Management LLC increased its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 12.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 58,273 shares of the medical technology company’s stock after buying an additional 6,223 shares during the period. Mutual of America Capital Management LLC owned 0.09% of Hill-Rom Holdings worth $4,114,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Texas Permanent School Fund increased its position in Hill-Rom Holdings by 4.3% in the third quarter. Texas Permanent School Fund now owns 45,382 shares of the medical technology company’s stock valued at $2,813,000 after buying an additional 1,888 shares in the last quarter. Americafirst Capital Management LLC bought a new position in Hill-Rom Holdings during the third quarter valued at approximately $1,799,000. Ameriprise Financial Inc. increased its position in Hill-Rom Holdings by 20.9% in the third quarter. Ameriprise Financial Inc. now owns 174,682 shares of the medical technology company’s stock valued at $10,826,000 after buying an additional 30,196 shares in the last quarter. Matarin Capital Management LLC bought a new position in Hill-Rom Holdings during the third quarter valued at approximately $7,415,000. Finally, Northern Trust Corp increased its position in Hill-Rom Holdings by 4.1% in the third quarter. Northern Trust Corp now owns 700,973 shares of the medical technology company’s stock valued at $43,447,000 after buying an additional 27,601 shares in the last quarter. 83.53% of the stock is currently owned by institutional investors.
Hill-Rom Holdings, Inc. (NYSE:HRC) traded up 2.20% on Friday, reaching $74.83. 875,333 shares of the company traded hands. The stock has a 50 day moving average of $72.69 and a 200-day moving average of $63.26. The stock has a market capitalization of $4.92 billion, a price-to-earnings ratio of 32.32 and a beta of 1.20. Hill-Rom Holdings, Inc. has a 1-year low of $47.46 and a 1-year high of $77.37.
Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings data on Friday, April 28th. The medical technology company reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.09. The firm had revenue of $678.90 million for the quarter, compared to analyst estimates of $654.27 million. Hill-Rom Holdings had a net margin of 5.44% and a return on equity of 19.12%. Hill-Rom Holdings’s revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.71 EPS. On average, equities analysts anticipate that Hill-Rom Holdings, Inc. will post $3.86 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This report was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2017/05/19/hill-rom-holdings-inc-hrc-stake-boosted-by-mutual-of-america-capital-management-llc.html.
HRC has been the topic of several recent analyst reports. Stifel Nicolaus initiated coverage on shares of Hill-Rom Holdings in a research note on Monday, January 23rd. They issued a “buy” rating and a $70.00 price target on the stock. Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research note on Tuesday, January 24th. Finally, Barclays PLC initiated coverage on shares of Hill-Rom Holdings in a research note on Wednesday, February 8th. They issued an “overweight” rating and a $70.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Hill-Rom Holdings has an average rating of “Buy” and a consensus price target of $73.00.
In related news, CEO John J. Greisch sold 207,987 shares of the business’s stock in a transaction dated Tuesday, March 7th. The shares were sold at an average price of $65.86, for a total value of $13,698,023.82. Following the sale, the chief executive officer now directly owns 301,565 shares in the company, valued at approximately $19,861,070.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Alton Shader sold 15,000 shares of the business’s stock in a transaction dated Thursday, March 16th. The shares were sold at an average price of $69.34, for a total transaction of $1,040,100.00. Following the completion of the sale, the senior vice president now owns 52,638 shares in the company, valued at $3,649,918.92. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.